InsidersTradesSigma
Browse the complete record of transactions filed by Murray Christopher K., Vice-Président Senior des Opérations Techniques. Director active across 1 company, notably Blueprint Medicines Corp. Aggregated, 2 disclosures have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €58k. History available since 1 March 2022. The latest transaction was filed on 3 March 2022 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations
Christopher K. Murray is the Senior Vice President of Technical Operations at Blueprint Medicines Corp. In this role, he oversees technical operations and ensures process efficiency. Christopher K. Murray brings expertise in technical operations and project management, thereby contributing to the organizational efficiency of Blueprint Medicines Corp.